[1]
Keshandehghan, A., Rostamian Tabari, A., Panahi, Y. and Gardaneh, M. 2024. Acquisition of Doxorubicin Resistance Induces Breast Cancer Cell Migration and Epithelial-Mesenchymal Transition that are Reversed by Shikonin-Metformin Synergy: Dox resistance and BC cell migration. Archives of Breast Cancer. 11, 2 (May 2024), 159–171. DOI:https://doi.org/10.32768/abc.2024112159-171.